These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9699704)

  • 1. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline.
    Pollock BG; Mulsant BH; Nebes R; Kirshner MA; Begley AE; Mazumdar S; Reynolds CF
    Am J Psychiatry; 1998 Aug; 155(8):1110-2. PubMed ID: 9699704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients.
    Mamo DC; Pollock BG; Mulsant B; Houck PR; Bensasi S; Miller MC; Redfern MS; Reynolds III CF
    Am J Geriatr Psychiatry; 2002; 10(2):199-205. PubMed ID: 11925281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.
    Solai LK; Pollock BG; Mulsant BH; Frye RF; Miller MD; Sweet RA; Kirshner M; Sorisio D; Begley A; Reynolds CF
    J Clin Psychopharmacol; 2002 Oct; 22(5):481-6. PubMed ID: 12352271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
    Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
    Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients.
    Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS
    Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.
    Mulsant BH; Pollock BG; Nebes RD; Miller MD; Little JT; Stack J; Houck PR; Bensasi S; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 1999; 60 Suppl 20():16-20. PubMed ID: 10513853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.
    Pollock BG; Laghrissi-Thode F; Wagner WR
    J Clin Psychopharmacol; 2000 Apr; 20(2):137-40. PubMed ID: 10770450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial.
    Weber E; Stack J; Pollock BG; Mulsant B; Begley A; Mazumdar S; Reynolds CF3rd
    Am J Geriatr Psychiatry; 2000; 8(3):245-50. PubMed ID: 10910424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.
    Nelson JC; Kennedy JS; Pollock BG; Laghrissi-Thode F; Narayan M; Nobler MS; Robin DW; Gergel I; McCafferty J; Roose S
    Am J Psychiatry; 1999 Jul; 156(7):1024-8. PubMed ID: 10401446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate.
    Yeragani VK; Roose S; Mallavarapu M; Radhakrishna RK; Pesce V
    Neuropsychobiology; 2002; 46(3):125-35. PubMed ID: 12422059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine versus nortriptyline in the continuation and maintenance treatment of depression in the elderly.
    Bump GM; Mulsant BH; Pollock BG; Mazumdar S; Begley AE; Dew MA; Reynolds CF
    Depress Anxiety; 2001; 13(1):38-44. PubMed ID: 11233459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine.
    Nebes RD; Pollock BG; Houck PR; Butters MA; Mulsant BH; Zmuda MD; Reynolds CF
    J Psychiatr Res; 2003; 37(2):99-108. PubMed ID: 12842163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients.
    Mulsant BH; Pollock BG; Nebes R; Miller MD; Sweet RA; Stack J; Houck PR; Bensasi S; Mazumdar S; Reynolds CF
    Am J Geriatr Psychiatry; 2001; 9(4):406-14. PubMed ID: 11739067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.
    Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K
    Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients.
    Nebes RD; Pollock BG; Mulsant BH; Kirshner MA; Halligan E; Zmuda M; Reynolds CF
    Psychopharmacol Bull; 1997; 33(4):715-20. PubMed ID: 9493484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients.
    Young RC; Alexopoulos GS; Shamoian CA; Kent E; Dhar AK; Kutt H
    Am J Psychiatry; 1985 Jul; 142(7):866-8. PubMed ID: 4014510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Double blind clinical study of mianserin and nortriptyline (author's transl)].
    Hoc J
    Acta Psychiatr Belg; 1978; 78(5):833-40. PubMed ID: 375687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical efficacy and side-effects of mianserin and nortriptyline in depressed out-patients: a double-blind randomized trial.
    Hoc J
    Curr Med Res Opin; 1982; 8(4):282-9. PubMed ID: 6759061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels and effects of nortriptyline in geriatric depressed patients.
    Kumar V; Smith RC; Reed K; Leelavathi DE
    Acta Psychiatr Scand; 1987 Jan; 75(1):20-8. PubMed ID: 3577837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.